Home/Filings/4/0000899243-21-023855
4//SEC Filing

Bishop John E 4

Accession 0000899243-21-023855

CIK 0001538927other

Filed

Jun 14, 8:00 PM ET

Accepted

Jun 15, 4:15 PM ET

Size

7.5 KB

Accession

0000899243-21-023855

Insider Transaction Report

Form 4
Period: 2021-06-14
Bishop John E
Chief Technology Officer
Transactions
  • Award

    Common Stock

    2021-06-14+22,00022,000 total
  • Award

    Stock Option (Right to Buy)

    2021-06-14+67,00067,000 total
    Exercise: $24.26Exp: 2031-06-13Common Stock (67,000 underlying)
Footnotes (2)
  • [F1]These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
  • [F2]25% of the shares subject to the stock option shall vest on June 14, 2022, and the remainder of the shares shall vest in equal monthly installments for a period of 36 months thereafter, subject to continued service with the Issuer.

Issuer

Forma Therapeutics Holdings, Inc.

CIK 0001538927

Entity typeother

Related Parties

1
  • filerCIK 0001308911

Filing Metadata

Form type
4
Filed
Jun 14, 8:00 PM ET
Accepted
Jun 15, 4:15 PM ET
Size
7.5 KB